Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Advancing rapid clinical development plan for ...

Poster presentation to highlight new data on MammaPrint® and BluePrint® utility for informing axillary surgery decisions in ...

All patients achieved 20/30 or better best corrected distance visual acuity (BCDVA)Significant IOP reduction at 18 months was also demonstrated with 100% of patients off all topical IOP-lowering ...

Too often, sales kickoffs fall short of their potential, becoming mere exercises in rote presentations and motivational ...

Southern Arkansas University social work faculty and students attended the Arkansas National Association of Social Workers ...

The poster will include clinical data as of an April 4, 2025 data cutoff from the Company's ongoing Phase 1/2 clinical trial evaluating azenosertib in combination with encorafenib and cetuximab in ...

Title: ALG-055009, a potent and selective thyroid hormone receptor beta agonist for the treatment of metabolic ...